Humanity ¡¤ Life Change ¡¤ Balance
HAUUL BIO is developing disease-specific antibodies for the balance between human health and happy life, and developing innovative new drugs by combining them with cell therapy products.
After introducing 'ShotCAR', the first cell therapy product platform, in 2020, it succeeded in developing the 'ModCAR' platform in 2021. As this platform can simplify the manufacturing process and therapy, HAUUL Bio is confident that it can help improve human cancer treatment through various anticancer treatment studies. In the future, all our employees are working hard on researches to increase corporate value and export technology by ¡®optimizing 6 or more drug candidates¡¯ and conducting ¡®non-clinical and clinical trials after developing the mass production process¡¯ on each platform. In order to realize our goal, HAUUL Bio is collaborating with industry, academia, research centers and hospitals to complement each other, forming a cooperative network for the development of drugs by providing generous support in helpful areas, and also working hard to attract external investments. Our efforts based on this innovative platform will become a game changer leading the technology in domestic and overseas cell therapy products. Thank you.